| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035113156 |
| P356 | DOI | 10.1186/1471-244X-12-166 |
| P932 | PMC publication ID | 3539952 |
| P698 | PubMed publication ID | 23046608 |
| P50 | author | Damiaan Denys | Q1873376 |
| Miranda Olff | Q47149809 | ||
| Martijn Figee | Q60700435 | ||
| P2093 | author name string | Brent C Opmeer | |
| Nienke Vulink | |||
| A Rosaura Polak | |||
| Anke B Witteveen | |||
| Rogier S Visser | |||
| P2860 | cites work | Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD) | Q24234332 |
| Clinical evaluation of paroxetine in post-traumatic stress disorder (PTSD): 52-week, non-comparative open-label study for clinical use experience | Q46207402 | ||
| Health care costs associated with posttraumatic stress disorder symptoms in women. | Q50717690 | ||
| Sex differences in posttraumatic stress disorder. | Q50924840 | ||
| Content validity, construct validity, and reliability of the WHOQOL-Bref in a population of Dutch adult psychiatric outpatients. | Q51931902 | ||
| Assessing the construct validity of three indicators of psychological distress in relation to perceived health and physical illness. | Q51958540 | ||
| The assessment of posttraumatic stress disorder: with the Clinician Administered PTSD Scale: Dutch results. | Q52882696 | ||
| The health status of the Dutch population as assessed by the EQ-6D. | Q53289375 | ||
| Aggregating health state valuations. | Q53595008 | ||
| Development of the World Health Organization WHOQOL-BREF Quality of Life Assessment | Q57947248 | ||
| Psychological factors and self-reports of muscle pain | Q68364360 | ||
| Evaluation of a brief cognitive-behavioral program for the prevention of chronic PTSD in recent assault victims | Q70843556 | ||
| Fluoxetine in posttraumatic stress disorder | Q72391733 | ||
| Fluoxetine in post-traumatic stress disorder. Randomised, double-blind study | Q73326033 | ||
| A scoring system for subjective health complaints (SHC) | Q73881206 | ||
| A controlled evaluation of cognitive behavioural therapy for posttraumatic stress in motor vehicle accident survivors | Q78679567 | ||
| [The MINI-International Neuropsychiatric Interview. A brief structured diagnostic psychiatric interview for DSM-IV en ICD-10 psychiatric disorders] | Q80574186 | ||
| When do trauma experts choose exposure therapy for PTSD patients? A controlled study of therapist and patient factors | Q82427669 | ||
| Comparison between paroxetine and behaviour therapy in patients with posttraumatic stress disorder (PTSD): A pilot study | Q88096127 | ||
| Psychological treatment of post-traumatic stress disorder (PTSD) | Q24244228 | ||
| Pharmacotherapy for post traumatic stress disorder (PTSD) | Q24244802 | ||
| The hospital anxiety and depression scale | Q27860968 | ||
| Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II | Q28260514 | ||
| Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial | Q28377040 | ||
| The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 | Q29547745 | ||
| Posttraumatic stress disorder in the National Comorbidity Survey | Q29616312 | ||
| EuroQol: the current state of play | Q33571065 | ||
| Multicenter, double-blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder | Q33945976 | ||
| Clinician-administered PTSD scale: a review of the first ten years of research | Q33949505 | ||
| Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study | Q33956204 | ||
| New approaches to combining pharmacotherapy and psychotherapy for posttraumatic stress disorder | Q34206188 | ||
| Brief eclectic psychotherapy v. eye movement desensitisation and reprocessing therapy for post-traumatic stress disorder: randomised controlled trial | Q34253385 | ||
| Consensus statement update on posttraumatic stress disorder from the international consensus group on depression and anxiety | Q34290395 | ||
| The development of a Clinician-Administered PTSD Scale | Q34308213 | ||
| A multidimensional meta-analysis of psychotherapy for PTSD. | Q34389083 | ||
| Prolonged Exposure versus Eye Movement Desensitization and Reprocessing (EMDR) for PTSD rape victims | Q34480365 | ||
| Sertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment | Q34515838 | ||
| Efficacy of sertraline in preventing relapse of posttraumatic stress disorder: results of a 28-week double-blind, placebo-controlled study | Q34519704 | ||
| Comparing the efficacy of EMDR and trauma-focused cognitive-behavioral therapy in the treatment of PTSD: a meta-analytic study | Q34532868 | ||
| Trauma and posttraumatic stress disorder in the community: the 1996 Detroit Area Survey of Trauma | Q34663514 | ||
| The lifetime prevalence of traumatic events and posttraumatic stress disorder in the Netherlands. | Q34994938 | ||
| Gender differences in posttraumatic stress disorder | Q36751972 | ||
| Predictive validity of a medication adherence measure in an outpatient setting | Q36925564 | ||
| Pharmacotherapy of posttraumatic stress disorder: a review of meta-analyses and treatment guidelines. | Q37377379 | ||
| A meta-analytic review of prolonged exposure for posttraumatic stress disorder | Q37765006 | ||
| Evidence-based pharmacotherapy of post-traumatic stress disorder (PTSD). | Q37907415 | ||
| A validation study of the Hospital Anxiety and Depression Scale (HADS) in different groups of Dutch subjects. | Q38457231 | ||
| Posttraumatic stress disorder and functioning and quality of life outcomes in a nationally representative sample of male Vietnam veterans | Q38473323 | ||
| A randomized clinical trial of eye movement desensitization and reprocessing (EMDR), fluoxetine, and pill placebo in the treatment of posttraumatic stress disorder: treatment effects and long-term maintenance. | Q39339996 | ||
| Gender differences in susceptibility to posttraumatic stress disorder | Q40761668 | ||
| Intrusive traumatic recollections and comorbid posttraumatic stress disorder in depressed patients | Q40775099 | ||
| Paroxetine in the treatment of chronic posttraumatic stress disorder: results of a placebo-controlled, flexible-dosage trial | Q43844465 | ||
| Fluoxetine versus placebo in posttraumatic stress disorder. | Q43942523 | ||
| Fluoxetine v. placebo in prevention of relapse in post-traumatic stress disorder | Q44160819 | ||
| Prescribing patterns for patients with posttraumatic stress disorder | Q44674305 | ||
| P921 | main subject | post-traumatic stress disorder | Q202387 |
| cognitive behavioral therapy | Q1147152 | ||
| P304 | page(s) | 166 | |
| P577 | publication date | 2012-10-09 | |
| P1433 | published in | BMC Psychiatry | Q15750257 |
| P1476 | title | Comparison of the effectiveness of trauma-focused cognitive behavioral therapy and paroxetine treatment in PTSD patients: design of a randomized controlled trial | |
| P478 | volume | 12 |
| Q35221041 | Breathing biofeedback as an adjunct to exposure in cognitive behavioral therapy hastens the reduction of PTSD symptoms: a pilot study |
| Q41955055 | Different neural modifications underpin PTSD after different traumatic events: an fMRI meta-analytic study. |
| Q34773861 | Feasibility, reliability and validity of a questionnaire on healthcare consumption and productivity loss in patients with a psychiatric disorder (TiC-P). |
| Q36815440 | Psychotraumatology in the Netherlands |
| Q28388813 | The effectiveness of cognitive behavioral therapy with respect to psychological symptoms and recovering autobiographical memory in patients suffering from post-traumatic stress disorder |
Search more.